530233 AUROLAB

Auro Laboratories Share Price

₹280.00 +0.3 (0.11%)

21 Dec, 2024 18:21

SIP TrendupStart SIP in AUROLAB

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 40.7%
  • Over 3 Month + 45.8%
  • Over 6 Month + 41.49%
  • Over 1 Year + 141.48%
SIP Lightning

Smart Investing Starts Here Start SIP with Auro Laboratories for Steady Growth!

Invest Now

Auro Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Auro Laboratories Financials

Auro Laboratories Technicals

EMA & SMA

Current Price
₹280.00
+ 0.3 (0.11%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹245.29
  • 50 Day
  • ₹231.17
  • 100 Day
  • ₹218.70
  • 200 Day
  • ₹199.45

Resistance and Support

286.47 Pivot Speed
  • R3 312.03
  • R2 305.02
  • R1 293.48
  • S1 274.93
  • S2 267.92
  • S3 256.38

What's your outlook on Auro Laboratories?

You can only vote for once

Auro Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results
2024-08-09 Quarterly Results
2024-05-25 Audited Results
2024-02-06 Quarterly Results
2023-11-09 Quarterly Results

Auro Laboratories F&O

Auro Laboratories Shareholding Pattern

No data available.

About Auro Laboratories

  • NSE Symbol
  • AUROLAB
  • BSE Symbol
  • 530233
  • ISIN
  • INE292C01011

Similar Stocks to Auro Laboratories

Auro Laboratories FAQs

Auro Laboratories share price is ₹280 As on 21 December, 2024 | 18:07

The Market Cap of Auro Laboratories is ₹174.5 Cr As on 21 December, 2024 | 18:07

The P/E ratio of Auro Laboratories is 28.3 As on 21 December, 2024 | 18:07

The PB ratio of Auro Laboratories is 4.2 As on 21 December, 2024 | 18:07

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23